The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients

Circulation. 1993 Dec;88(6):2541-7. doi: 10.1161/01.cir.88.6.2541.

Abstract

Background: Patients with hypercholesterolemia have a reduced response to endothelium-dependent vasodilators. However, the regulatory function of the endothelium on vascular tone is mediated through the release of several vasoactive substances; therefore, a reduced response to endothelium-dependent agents does not identify which of the factors released by the endothelium is involved in this abnormality.

Methods and results: To investigate the role of nitric oxide in the endothelium-dependent vasodilation in hypercholesterolemia, we studied the effect of NG-monomethyl-L-arginine (L-NMMA), an inhibitor of endothelial nitric oxide synthesis, on basal vascular tone and on the responses to acetylcholine, an endothelium-dependent vasodilator, and to sodium nitroprusside, a direct smooth muscle dilator. The study included 33 hypercholesterolemic patients (17 men; 51 +/- 8 years; plasma cholesterol, > or = 240 mg/dL) and 23 normal controls (12 men; 48 +/- 7 years; plasma cholesterol, < 210 mg/dL). Drugs were infused into the brachial artery, and the response of the forearm vasculature was measured by strain-gauge plethysmography. Basal blood flow and vascular resistance were similar in hypercholesterolemic patients and normal controls (3.1 +/- 1 versus 2.6 +/- 0.8 mL/min per 100 mL and 32.1 +/- 13 versus 36.1 +/- 12 mm Hg/mL-1.min-1.100 mL-1, respectively). The reduction in basal blood flow and increase in vascular resistance produced by L-NMMA were not significantly different between the two groups. L-NMMA markedly blunted the response to acetylcholine in normals (maximum flow decreased from 16.4 +/- 8 to 7.0 +/- 3; P < .005); however, the arginine analogue did not significantly modify the response to acetylcholine in the hypercholesterolemic patients (maximum flow, 11.1 +/- 8 versus 10.0 +/- 8). L-NMMA did not modify the vasodilator response to sodium nitroprusside in either controls or patients.

Conclusions: These findings indicate that hypercholesterolemic patients have a defect in the bioactivity of nitric oxide that may explain their impaired endothelium-dependent vascular relaxation.

MeSH terms

  • Acetylcholine / pharmacology
  • Adult
  • Aged
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Blood Flow Velocity / drug effects
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiopathology*
  • Female
  • Forearm / blood supply
  • Humans
  • Hypercholesterolemia / physiopathology*
  • Male
  • Middle Aged
  • Nitric Oxide / antagonists & inhibitors
  • Nitric Oxide / physiology*
  • Nitroprusside / pharmacology
  • Vascular Resistance / drug effects
  • Vasodilation / drug effects
  • Vasodilation / physiology*
  • omega-N-Methylarginine

Substances

  • Nitroprusside
  • omega-N-Methylarginine
  • Nitric Oxide
  • Arginine
  • Acetylcholine